Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Hepatic Dysfunction”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 0 results

Early research (Phase 1)Study completedNCT02795637
What this trial is testing

Study of the What the Body Does to the Drug in Subjects With Mild, Moderate, and Severe Liver Dysfunction

Who this might be right for
Attention Deficit Hyperactivity Disorder (ADHD)Binge-Eating Disorder Disorder
Sumitomo Pharma America, Inc. 44
Early research (Phase 1)Study completedNCT05185011
What this trial is testing

Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild ,Moderate Hepatic Insufficiency and Normal Liver Function

Who this might be right for
Erectile DysfunctionPulmonary Arterial Hypertension
Vigonvita Life Sciences 24
Early research (Phase 1)Study completedNCT03890809
What this trial is testing

An Investigational Study of BMS-986165 in Participants With Normal Liver Function and Participants With Mild to Severe Liver Damage

Who this might be right for
Liver DysfunctionHealthy Volunteers
Bristol-Myers Squibb 32
Early research (Phase 1)Study completedNCT00049400
What this trial is testing

S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
SWOG Cancer Research Network 78
Early research (Phase 1)Study completedNCT00976326
What this trial is testing

A Trial Investigating the Pharmacokinetic (Mode of Action in the Body) and Safety Profiles of NN1250 (Insulin Degludec) in Subjects With Various Degrees of Impaired Liver Function and in Subjects With Normal Liver Function

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 12
Testing effectiveness (Phase 2)Study completedNCT00867698
What this trial is testing

AST-120 Used to Treat Mild Hepatic Encephalopathy

Who this might be right for
Mild Hepatic Encephalopathy
Ocera Therapeutics 148